Use of a multistate model in survival predictions in cardiology studies

Natalia Montoya1,2, Alicia Quirós2, José M de la Torre-Hernández1

  • 1Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, España Servicio de Cardiología Hospital Universitario Marqués de Valdecilla Instituto de Investigación Sanitaria Valdecilla (IDIVAL) Santander España.

Insights

Multistate models enhance survival analysis in cardiology by predicting disease progression. These models offer detailed insights into patient outcomes, improving prognostic accuracy for antithrombotic therapies.

Area of Science:

  • Cardiovascular Medicine
  • Biostatistics
  • Medical Informatics

Background:

  • Multistate models are valuable for survival analyses.
  • Disease progression modeling is crucial in interventional cardiology.

Purpose of the Study:

  • To model disease progression in interventional cardiology using a multistate model.
  • To assess the efficacy and prognosis of antithrombotic therapies in elderly patients with atrial fibrillation.

Main Methods:

  • Fitted a multistate model to the PACO-PCI database (1057 patients).
  • Defined 4 states: treatment, myocardial infarction/revascularization, bleeding, and death.
  • Compared with multivariate Cox models.

Main Results:

  • Identified common survival factors: PreciseDAPT, HAS-BLED, anemia, diabetes, chronic kidney disease, vessels treated, and left ventricular function.
  • Multistate models revealed specific transition influences (e.g., hemorrhage impact on myocardial infarction/revascularization).
  • Multistate models provide transition-specific predictor insights, unlike Cox models.

Conclusions:

  • Multistate models offer advantages in survival analysis.
  • These models enable individualized patient predictions based on clinical characteristics and disease progression.
Abstract

Related Concept Videos

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
487
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
930
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
702
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
795